Media Contact: Melody Udell
Our team would love to meet with you to demonstrate how MMIT, Panalgo, and our NorstellaLinQ data asset deliver end-to-end support from clinical trial planning to market access intelligence, powered by real-world evidence, AI-enabled analytics, and expert-level support.
Join 4,000+ managed care pharmacy professionals at AMCP 2026 in Nashville, TN, April 13-16. Explore cutting-edge education, earn CE credits, and dive into Al, real-world evidence, precision medicine and other emerging health care trends. Network with leaders from health plans, PBMs, pharma, and more.
Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future. Asembia’s AXS26 Summit will return to the Wynn & Encore Las Vegas April 26-30, 2026.
The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger. This is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
AMCP Nexus attracts more than 2,500 managed care decision-makers each fall. Attendees include individuals from health plans, PBMs, biopharmaceutical companies, consultants, and other leaders working within managed care pharmacy.
PharmaVoice tapped MMIT’s Madeline Verbeke and Evaluate’s Mark Lansdell for insights on market forces in 2026. Madeline addresses the obesity market’s expansion with the growth of oral and combination drugs, while Mark highlights expectations for high-value U.S. pharma / Chinese biotech deals in 2026.
This article from Drug Discovery & Development highlights the market’s strong M&A momentum and a surging Chinese deal landscape, featuring quotes from Evaluate’s Ben Folwell and Mark Lansdell. MMIT’s Madeline Verbeke shares her insights on obesity therapeutics, as new oral drugs are expected to capture meaningful market share.
For this article on GLP-1 market dynamics, Investor’s Business Daily reached out to MMIT CCO Jayne Hornung for her insights on pricing, affordability, and whether the oral version of these drugs will reach a previously untapped market.
